Axonal pathology and demyelination in viral models of multiple sclerosis

Jane E Libbey1, Thomas E Lane, Robert S Fujinami

  • 1Department of Pathology, University of Utah, 15 North Medical Drive East, 2600A EEJMRB, Salt Lake City, UT 84112, USA.

Discovery Medicine
|August 6, 2014
PubMed

Insights

Environmental factors like viral infections may trigger multiple sclerosis (MS) in genetically susceptible individuals. Pre-clinical models show viral infections can cause early axonal damage, preceding demyelination and contributing to MS severity.

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Disorders
  • Viral Pathogenesis

Background:

  • Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the CNS.
  • Genetic factors contribute to MS, but do not solely determine disease development.
  • Increasing MS rates, especially in women, highlight the role of environmental triggers like viral infections.

Purpose of the Study:

  • To review pathological aspects of pre-clinical viral models for MS.
  • To investigate the link between viral infections, axonal damage, and demyelination in MS.
  • To explore the potential of early axonal damage as a precursor to immune-mediated demyelination.

Main Methods:

  • Analysis of pathological data from two pre-clinical viral models of MS.
  • Comparison of experimental findings in susceptible mice with human MS observations.
  • Review of literature on viral infections and CNS autoimmunity.

Main Results:

  • Experimental viral infections in susceptible mice induce axonal degeneration alongside demyelination.
  • Axonal damage, or Wallerian degeneration, is observed in the CNS of MS patients.
  • Early axonal damage may precede and facilitate later immune-mediated demyelination.

Conclusions:

  • Pre-clinical viral models support the role of viral infections in MS pathogenesis.
  • Axonal damage is a significant pathological feature in MS, contributing to disability.
  • Understanding early axonal damage mechanisms is crucial for developing effective MS therapies.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
17
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
16
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
52